Riskpilot← Back to searchSign inGet full accessDREVELIN HELSE AS
ASActiveOrg 919073721Møllendalsbakken 6, 5009 BergenOther human health activities n.e.c. · NACE 8699Est. 20175 employees
Revenue 2024
NOK 4,9M
+21% vs 2023
EBITDA margin
8.3%
+400% vs 2023
Equity ratio
12.4%
Financial strength
Net profit 2024
NOK 330K
+311% vs 2023
| Revenue | NOK 4,9M | +21% |
| EBITDA | NOK 406K | +400% |
| Net profit | NOK 330K | +311% |
| Total assets | NOK 1,5M | +36% |
| Equity | NOK 185K | +229% |
| Employees | 5 | — |
Legal name
DREVELIN HELSE AS
Org number
919073721
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
1. juni 2017
Share capital
NOK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene eller styrets leder alene.
Company purpose
Fotterapeutisk behandling og behandling av diabetes, samt salg av tjenester og produkter som naturlig har sammenheng med dette.
Address
Møllendalsbakken 6, 5009 Bergen
Phone
+4740551870
Email
torild@drevelinhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 918 | 3 382 | 3 458 | 4 047 | 4 880 |
| Staff expenses | −1 204 | −2 093 | −2 273 | −2 845 | −3 144 |
| EBITDA | 182 | 147 | 22 | −135 | 406 |
| Depreciation & amort. | −1 | −9 | −14 | −20 | −28 |
| EBIT | 181 | 137 | 8 | −155 | 378 |
| Net financials | −1 | −2 | −4 | −1 | 3 |
| Profit before tax | 180 | 135 | 5 | −156 | 381 |
| Tax | −0 | −0 | −0 | −0 | 52 |
| Net profit | 180 | 135 | 5 | −156 | 330 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 515 | 846 | 1 020 | 1 098 | 1 493 |
| Equity | −128 | 7 | 12 | −144 | 185 |
| Long-term debt | 316 | 327 | 376 | 377 | 380 |
| Short-term debt | 326 | 511 | 632 | 864 | 928 |
| Total debt | 643 | 838 | 1 008 | 1 242 | 1 308 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20202024
Equity ratio
12.4%
This company
38.2%
Market median
-68% vs market
20202024
Return on equity
177.8%
This company
18.4%
Market median
+866% vs market
20202024
Net profit margin
6.8%
This company
8.1%
Market median
-16% vs market
20202024
Asset turnover
3.27×
This company
1.12×
Market median
+192% vs market
20202024
Debt / equity
7.05×
This company
0.62×
Market median
-1037% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TK Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2017 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Drevelin Ortopedi As
DREVELIN HELSE AS Board members of DREVELIN HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torild Karin Moldøen | Chief Executive Officer | 0 companies |
| Tore Klepsvik | Board of Directors | 0 companies |
| Petter Jørgen Christensen | Chairman | 0 companies |
| Finn Høydal | Board of Directors | 0 companies |
| Claudia Ximena Garces Tobar | Board of Directors | 0 companies |
| Katrine Moldøen | Board of Directors | 0 companies |